Effect of LPS On the Clotting System

  • Alexander M. Abdelnoor


The activation of the clotting system is one of the body’s natural defense mechanisms. In addition to the formation of a fibrin clot that seals an injured vessel, other systems are triggered such as fibrinolytic, kinin, and complement. As a consequence, several mediators are produced that are involved in nonspecific resistance to infections and tumors.


Tissue Factor Human Platelet Clotting System Tissue Factor Activity Rabbit Platelet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aasen, A. O., Frolich, W., Sangstad, O. D., and Amundsen, E., 1978a, Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs, Eur. Surg. Res. 10:50.PubMedCrossRefGoogle Scholar
  2. Aasen, A. O., Ohlsson, K., Larsbraaten, M., and Amundsen, E., 1978b, Changes in plasminogen levels, plasmin activity and activity of antiplasmins during endotoxin shock in dogs, Eur. Surg. Res. 10:63.PubMedCrossRefGoogle Scholar
  3. Abdelnoor, A. M., Kassem, H., Bikhazi, A. B., and Nowotny, A., 1980, Effect of gramnegative bacterial lipopolysaccharide derived polysaccharides, glycolipids, and lipopolysaccharides on rabbit and human platelets in vitro, Immunobiology 157:145.PubMedCrossRefGoogle Scholar
  4. Abdelnoor, A. M., Johnson, A. G., Anderson-Imbert, A., and Nowotny, A., 1981, Immunization against bacteria- and endotoxin-induced hypotension, Infect. Immun. 32:1093.PubMedGoogle Scholar
  5. Bjornson, H. S., and Hill, E. O., 1973, Bacteriodaceae in thromboembolic disease: Effect of cell wall components on blood coagulation in vivo and in vitro, Infect. Immun. 8:911.PubMedGoogle Scholar
  6. Brown, D. L., and Lachmann, P. J., 1973, The behaviour of complement and platelets in lethal endotoxin shock in rabbits, Int. Arch. Allergy Appl. Immunol. 45:193.PubMedCrossRefGoogle Scholar
  7. Chang, H., Thompson, J. J., and Nowotny, A., 1974, Release of colony stimulating factor (CSF) by non-endotoxic breakdown product of bacterial lipopolysaccharides, Immunol. Commun. 3:401.Google Scholar
  8. Cohen, P., and Gardner, F. M., 1966, Thrombocytopenia as a laboratory complication of gram negative bacteremic infection, Arch. Internal Med. 117:113.CrossRefGoogle Scholar
  9. Das, J., Schwartz, A. A., and Folkwon, J., 1973, Clearance of endotoxin by platelets: Role in increasing the accuracy of the Limulus gelation test and in combating experimental endotoxemia, Surgen 74:235.Google Scholar
  10. Davis, R. B., Mecker, W. R., and McQuarrie, D. C., 1960, Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets, Circ. Res. 8:234.PubMedGoogle Scholar
  11. Davis, R. B., Mecker, W. R., and Bailey, W. L., 1961, Serotonin release after injection of E. coli endotoxins in the rabbit, Fed. Proc. 20:261.Google Scholar
  12. Des Prez, R. M., and Bryant, R. E., 1966, Effect of bacterial endotoxin on rabbit platelets. IV. The divalent ion requirement of endotoxin-induced and immunologically induced platelet injury,J. Exp. Med. 124:971.PubMedCrossRefGoogle Scholar
  13. Des Prez, R. M., and Marney, S. R., Jr., 1971, in: The Circulating Platelets (S. A. Johnson, ed.), p. 415, Academic Press, New York.Google Scholar
  14. Des Prez, R. M., Horowitz, H. I., and Hook, E. W., 1961, Effect of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro, J. Exp. Med. 114:857.CrossRefGoogle Scholar
  15. Edwards, R. L., Rickles, F. R., and Babrove, A. M., 1979, Mononuclear cell tissue factor: Cell of origin and requirements for activation, Blood 54:359.PubMedGoogle Scholar
  16. Eichenberger, E., 1955, Fibrinolyse nach intravenöser Injektion bakterieller Pyrogene, Acta Neuroveg. 11:201.CrossRefGoogle Scholar
  17. Fong, J. S. C., and Good, R. A., 1971, Prevention of the localized and generalized Shwartzman reaction by an anticomplementary agent: Cobra venom factors, J. Exp. Med. 134:642.PubMedCrossRefGoogle Scholar
  18. Fong, J. S. C., White, J. C., and Good, R. A., 1974, Inhibition of endotoxic lipopolysaccharide-mediated platelet aggregation by cobra venom anticomplementary factor, Blood 44:399.PubMedGoogle Scholar
  19. Gallimore, M. J., Aasen, A. O., and Amundsen, E., 1978, Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs, Haemostasis 7:79.PubMedGoogle Scholar
  20. Galloway, R. E., Levin, J., Butler, T., et al., 1977, Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection, Am. J. Med. 63:933.PubMedCrossRefGoogle Scholar
  21. Garner, R., Chater, B. V., and Brown, D. L., 1974, The role of complement in endotoxic shock and disseminated intravascular coagulation: Experimental observations in the dog, Br. J. Haematol. 28:393.PubMedCrossRefGoogle Scholar
  22. Hawiger, J., 1978, Platelets in Sanarelli-Shwartzman reaction and in human sepsis, in: Platelets: A Multidisciplinary Approach (G. de Gaetano and S. Garattini, eds.), p. 321, Raven Press, New York.Google Scholar
  23. Hawiger, J., Hawiger, A., Steckley, S., Timmons, S., and Cheng, C., 1977, Membrane changes in human platelets induced by lipopolysaccharide endotoxin, Br. J. Haematol. 35:285.PubMedCrossRefGoogle Scholar
  24. Henson, P. M., 1969, The adherence of leucocytes and platelets induced by fixed IgG antibody or complement, Immunology 16:107.PubMedGoogle Scholar
  25. Hiller, E., Saal, J. G., and Riethmueller, G., 1977, Procoagulant activity of activated monocytes, Haemostasis 6:347.PubMedGoogle Scholar
  26. Horder, M. H., and Manrique, R., 1965, Aktivierung der Blutgerinnung durch ein bakterielles Endotoxin beim Menschen unter Kumarintherapy, Klin. Wochenschr. 43:397.CrossRefGoogle Scholar
  27. Humphrey, J. H., and Jacques, R., 1955, The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro), J. Physiol. (London) 128:9.Google Scholar
  28. Kane, M. A., May, J. E., and Frank, M. M., 1973, Interaction of the classical and alternate complementary pathway with endotoxin lipopolysaccharide: Effect on platelets and blood coagulation,J. Clin. Invest. 52:370.PubMedCrossRefGoogle Scholar
  29. Kimball, H. R., Mclmon, K. L., and Wolfe, S. M., 1972, Endotoxin-induced kinin production in man, Proc. Soc. Exp. Biol. Med. 139:1078.PubMedGoogle Scholar
  30. Landy, M., and Weidanz, W. P., 1964, Natural antibodies against gram negative bacteria, in: Bacterial Endotoxins (M. Landy and W. Braun, eds.), p. 275, Rutgers University Press, New Brunswick, N.J.Google Scholar
  31. Lerner, R. G., Goldstein, R., and Cummings, G., 1977, Endotoxin induced disseminated intravascular clotting: Evidence that it is mediated by neutrophil production of tissue factor, Thromb. Res. 11:253.PubMedCrossRefGoogle Scholar
  32. Lüderitz, O., Staub, A. M., and Westphal, O., 1966, Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae, Bactenol. Rev. 30:192.Google Scholar
  33. Lüscher, E. F., and Pfueller, S. L., 1978, Platelets as targets of immunological reactions, in: Platelets: A Multidisciplinary Approach (G. de Gaetano and S. Garattini, eds.), p. 261, Raven Press, New York.Google Scholar
  34. Mason, J. W., Kleeberg, U., Dolan, P., and Colman, R. W., 1970, Plasma kallikrein and Hageman factor in gram negative bacteremia, Ann. Intern. Med. 73:545.PubMedGoogle Scholar
  35. Michael, J. G., Whitby, J. L., and Landy, M., 1962, Studies on natural antibodies to gram negative bacteria,J. Exp. Med. 115:3.CrossRefGoogle Scholar
  36. Morrison, D. C., and Cochrane, C. G., 1974, Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins),J. Exp. Med. 140:797.PubMedCrossRefGoogle Scholar
  37. Morrison, D. C., and Kline, L. F., 1977, Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS), J. Immunol. 118:362.PubMedGoogle Scholar
  38. Muller-Berghans, G., 1978, Ehe role of platelets, leucocytes and complement in the activation of intravascular coagulation by endotoxins, in: Platelets: A Multidisciplinary Approach (G. de Gaetano and S. Garattini, eds.), p. 303, Raven Press, New York.Google Scholar
  39. Muller-Berghans, G., and Schneberger, R., 1971, Hageman factor activation in the generalized Shwartzman reaction induced by endotoxins, Br. J. Haematol, 21:513.CrossRefGoogle Scholar
  40. Nagayama, M., Zucker, M. B., and Beller, F. K., 1971, Effect of a variety of endotoxins on human and rabbit platelet function, Thromb. Diath. Haemorrh. 26:467.PubMedGoogle Scholar
  41. Nowotny, A., 1969, Molecular aspects of endotoxic reactions, Bactenol. Rev. 33:72.Google Scholar
  42. Nowotny, A., 1971, Relation of structure and biological activity of bacterial endotoxins, Naturwissenschaften 58:397.PubMedCrossRefGoogle Scholar
  43. Nowotny, A., 1977, Relation of structure to function in bacterial endotoxins, in: Microbiology 1977 (D. Schlessinger, ed.), American Society for Microbiology, Washington, D.C.Google Scholar
  44. Nowotny, A., Cundy, K., Neale, N., Nowotny, A. M., Radvany, R., Thomas, S., and Tripodi, D., 1966, Relation of structure to function in bacterial O-antigens. IV. Fractionation of the components, Ann. N.Y. Acad. Sci. 133:586.PubMedCrossRefGoogle Scholar
  45. Nowotny, A., Behling, U. H., and Chang, H. L., 1975, Relation of structure to function in bacterial endotoxins. VIII. Biological activities in a polysaccharide-rich fraction, J. Immunol. 115:199.PubMedGoogle Scholar
  46. Prydz, H., Allison, A. C., and Schorlemmer, H. U., 1977, Further link between complement activation and blood coagulation, Nature (London) 270:173.CrossRefGoogle Scholar
  47. Ream, V.J., Deykin, D., Gurewich, V., and Wessler, S., 1965, The aggregation of human platelets by bacterial endotoxins,J. Lab. Clin. Med. 66:245.PubMedGoogle Scholar
  48. Rickles, F. R., Levine, J., Hardin, J. A., et al., 1977, Tissue factor generation by human mononuclear cells: Effects of endotoxin and dissociation of tissue factor generation from mitogenic response,J. Lab. Clin. Med. 89:792.PubMedGoogle Scholar
  49. Rodriguez-Erdmann, F., 1964, Studies on pathogenesis of the generalized Shwartzman reaction. III. Frigger mechanism for the activation of the prothrombin molecule, Thromb. Diath. Haemorrh. 12:471.Google Scholar
  50. Rothberger, H., Zimmerman, T. S., Spiegelberg, H. L., and Vaughan, J. H., 1977, Leucocyte procoagulant activity: Enhancement of production in vitro by IgG and antigen-antibody complexes,J. Clin. Invest. 59:549.PubMedCrossRefGoogle Scholar
  51. Semeraro, N., Colucci, M., Fumarola, D., and Vermylen, J., 1978a, Platelets and endotoxins: Complement-dependent and complement-independent interactions, in: Platelets: A Multidisciplinary Approach (G. de Gaetano and S. Garattini, eds.), Raven Press, New York.Google Scholar
  52. Semeraro, N., Fumarola, D., Merters, F., and Vermylen, J., 1978b, Evidence that endotoxins enhance the factor X activation activity of washed human platelets, Br. J. Haematol. 38:243.CrossRefGoogle Scholar
  53. Spielvogel, A. R., 1967, An ultrastructural study of the mechanism of platelet-endotoxin interaction,J. Exp. Med. 126:235.PubMedCrossRefGoogle Scholar
  54. Springer, G. F., and Adye, J. C., 1975, Endotoxin-binding substances from human leucocytes and platelets, Infect. Immun. 12:978.PubMedGoogle Scholar
  55. Tonooka, T., 1978, Development of tissue factor activity in mononuclear cells cultured in vitro, Tohoku J. Exp. Med. 125:213.CrossRefGoogle Scholar
  56. Ulevitch, R. J., Cochrane, C. G., Henson, P. M., Morrison, D. C., and Doc, W. F., 1975, Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation,J. Exp. Med. 142:1570.PubMedCrossRefGoogle Scholar
  57. Ulevitch, R. J., Cochrane, C. G., Bangs, K., et al., 1978, The effect of complement depletion on bacterial lipopolysaccharide induced hemodynamic and hematologic changes in the rhesus monkey, Am. J. Pathol. 92:227.PubMedGoogle Scholar
  58. Von Kaulla, K. N., 1958, Intravenous protein-free pyrogen: A powerful fibrinolytic agent in man, Circulation 17:187.Google Scholar
  59. Walker, R. I., Porvaznik, M., Egan, J. E., and Miller, A. M., 1979, Hageman factor activation and tight junction disruption in mice challenged with attenuated endotoxin, Experientia 35:759.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Alexander M. Abdelnoor
    • 1
  1. 1.Department of Microbiology, Faculty of MedicineAmerican University of BeirutBeirutLebanon

Personalised recommendations